EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Intraocular involvement of Mantle cell lymphoma

Madiha Iqbal, Yennifer Gil Castano, Taimur Sher, Mohamed A Kharfan-Dabaja

Hematology/Oncology and Stem Cell Therapy · 2021-04 · 14 (2) · 147-152

DOI: 10.1016/j.hemonc.2019.03.002 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hematology/Oncology and Stem Cell Therapy, 2021-04. Verfasst von Madiha Iqbal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA. Electronic address: Iqbal.madiha@ma…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Janssen and Incyte Corp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphomatous involvement of the ocular adnexal region (OAR) is generally rare; however, it constitutes the most common ocular malignancy. Most cases of ocular adnexal lymphomas are extra nodal marginal zone B cell lymphomas. Mantle cell lymphoma involvement (MCL) of the OAR is a less common presentation compared with other lymphomas and it has been reported anecdotally. Studies have suggested an association of OAR involvement with poor prognosis. Here, we report the case of a 61 year old man who started experiencing conjunctival erythema which was followed by development of bilateral proptosis. The diagnosis of Stage IV Mantle cell lymphoma with OAR involvement was confirmed 5 months after patient onset of symptomatology. He underwent treatment with systemic chemotherapy, which was followed by high-dose chemotherapy and autologous hematopoietic cell transplant. He is currently day +100 from his transplant and is in complete remission. A review of the literature regarding ocular involvement of MCL is also summarized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsErythemaEye NeoplasmsHematopoietic Stem Cell TransplantationHumansLymphoma, Mantle-CellMaleMiddle Aged

Stichwörter der Autor:innen

Mantle cell lymphoma involvementOcular adnexal region

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA. Electronic address: Iqbal.madiha@mayo.edu.
  • Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.

Förderung

  • Janssen and Incyte Corp

Zitieren

APA

Iqbal, M., Castano, Y. G., Sher, T., & Kharfan-Dabaja, M. A. (2021). Intraocular involvement of Mantle cell lymphoma. Hematology/Oncology and Stem Cell Therapy, 14(2), 147-152. https://doi.org/10.1016/j.hemonc.2019.03.002

Vancouver

Iqbal M, Castano YG, Sher T, Kharfan-Dabaja MA. Intraocular involvement of Mantle cell lymphoma. Hematology/Oncology and Stem Cell Therapy. 2021;14(2):147-152. doi:10.1016/j.hemonc.2019.03.002

BibTeX
@article{Iqbal2021,
  author = {Iqbal, Madiha and Castano, Yennifer Gil and Sher, Taimur and Kharfan-Dabaja, Mohamed A},
  title = {Intraocular involvement of Mantle cell lymphoma},
  journal = {Hematology/Oncology and Stem Cell Therapy},
  year = {2021},
  volume = {14},
  number = {2},
  pages = {147--152},
  doi = {10.1016/j.hemonc.2019.03.002}
}
Kostenlos starten →